Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiome -- CRME -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (127)	1/22/2007 11:59:09 AM
From: Ian@SI	Respond to of 285

Saw some unknown to me outfit (Versant) raise its target price to C$18 (about $16USD). I still don't understand why the stock price is moving at it is, so I'll continue to stay away for the time being.

To: tuck who wrote (127)	2/8/2007 2:09:20 PM
From: dr.praveen	Respond to of 285

Cardiome To Hold Analyst and Investor Day Thursday February 8, 1:04 pm ET VANCOUVER, Feb. 8 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will host an Analyst and Investor Day for equity analysts and institutional investors on Wednesday, February 28, 2007 in New York City. Cardiome senior management will deliver presentations providing clinical, regulatory and commercial updates, followed by a luncheon panel entitled "Evolving Treatment Paradigms for Atrial Fibrillation" featuring several cardiology thought leaders. The event is scheduled to run from 10:00am to 2:00pm EST, and a live webcast will be available on Cardiome's website at www.cardiome.com.